MAI 13G

Company

Trevi Therapeutics, Inc.

Filed

April 8, 2022

Accession Number

0001040197-22-000003

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →